Alberto Baroja‐Mazo

4.3k total citations · 1 hit paper
66 papers, 3.3k citations indexed

About

Alberto Baroja‐Mazo is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Alberto Baroja‐Mazo has authored 66 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 17 papers in Immunology and 15 papers in Surgery. Recurrent topics in Alberto Baroja‐Mazo's work include Inflammasome and immune disorders (18 papers), Adenosine and Purinergic Signaling (15 papers) and Organ Transplantation Techniques and Outcomes (10 papers). Alberto Baroja‐Mazo is often cited by papers focused on Inflammasome and immune disorders (18 papers), Adenosine and Purinergic Signaling (15 papers) and Organ Transplantation Techniques and Outcomes (10 papers). Alberto Baroja‐Mazo collaborates with scholars based in Spain, United Kingdom and France. Alberto Baroja‐Mazo's co-authors include Pablo Pelegrı́n, María Barberà-Cremades, Ana Isabel Gómez Córdoba, Carlos Martínez, Vincent Compan, Fatima Martín‐Sánchez, J.A. Pons, Beatriz Revilla‐Nuin, David Brough and Gloria López‐Castejón and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Immunity.

In The Last Decade

Alberto Baroja‐Mazo

64 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response

2014 640 citations Alberto Baroja‐Mazo, Fatima Martín‐Sánchez et al. Nature Immunology profile →

Peers

Countries citing papers authored by Alberto Baroja‐Mazo

Since Specialization

Citations

This map shows the geographic impact of Alberto Baroja‐Mazo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Baroja‐Mazo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Baroja‐Mazo more than expected).

Fields of papers citing papers by Alberto Baroja‐Mazo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Baroja‐Mazo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Baroja‐Mazo. The network helps show where Alberto Baroja‐Mazo may publish in the future.

Co-authorship network of co-authors of Alberto Baroja‐Mazo

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Baroja‐Mazo. A scholar is included among the top collaborators of Alberto Baroja‐Mazo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Baroja‐Mazo. Alberto Baroja‐Mazo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Longitudinal biomarker progression and validation for predicting operational tolerance in a prospective multicenter liver transplantation immunosuppression withdrawal trial 2025 ·PLoS ONE ·(unknown), (unknown), Mercedes Iñarrairaegui, (unknown), Valle Cadahía, (unknown), (unknown), (unknown), (unknown), (unknown), Gloria Sánchez‐Antolín, (unknown), Pablo Ramı́rez, (unknown), Alberto Baroja‐Mazo, J.I. Herrero, J.A. Pons	0
2	Efficacy of Self-Expandable Absorbable Stents During Liver Transplant to Minimize Early Biliary Complications 2024 ·Annals of Surgery ·Víctor López‐López, Christoph Kuemmerli, (unknown), (unknown), Pedro Antonio Cáscales-Campos, Alberto Baroja‐Mazo, (unknown), (unknown), (unknown), Francisco Sánchez‐Bueno, Pablo Ramírez, (unknown)	3
3	Operational tolerance research in liver transplantation: a bibliometric analysis using a new web resource 2024 ·SHILAP Revista de lepidopterología ·(unknown), Juan José Martínez-García, (unknown), (unknown), Pablo Ramírez, J.A. Pons, Alberto Baroja‐Mazo	0
4	Selecting the Appropriate Downstaging and Bridging Therapies for Hepatocellular Carcinoma: What Is the Role of Transarterial Radioembolization? A Pooled Analysis 2023 ·Cancers ·Víctor López‐López, (unknown), Christoph Kuemmerli, (unknown), Dilmurodjon Eshmuminov, (unknown), Alberto Baroja‐Mazo, Pedro Antonio Cáscales-Campos, (unknown), J.A. Pons, (unknown), Francisco Sánchez‐Bueno, R Robles, Pablo Ramı́rez	13
5	Time since liver transplant and immunosuppression withdrawal outcomes: Systematic review and individual patient data meta‐analysis 2023 ·Liver International ·Christian Appenzeller‐Herzog, (unknown), Tim Mathes, Alberto Baroja‐Mazo, Andrzej Chruscinski, Sandy Feng, J.I. Herrero, María‐Carlota Londoño, George Mazariegos, (unknown), J.A. Pons, Alberto Sánchez‐Fueyo, Kayo Waki, Julien Vionnet	2
6	New challenges in cholangiocarcinoma candidates for elective surgery: harnessing the microbiome dysbiosis 2023 ·Langenbeck s Archives of Surgery ·Oriana Lo Re, Víctor López‐López, (unknown), (unknown), Dilmurodjon Eshmuminov, (unknown), Kohei Miura, Alberto Baroja‐Mazo, Pablo Ramı́rez, R Robles, Bruno Ramos‐Molina	3
7	Endothelial cell activation mediated by cold ischemia-released mitochondria is partially inhibited by defibrotide and impacts on early allograft function following liver transplantation 2023 ·Biomedicine & Pharmacotherapy ·(unknown), David García‐Bernal, (unknown), (unknown), (unknown), Felipe Alconchel, L. Martínez‐Alarcón, Víctor López‐López, Antonio Ríos, Pedro Cascales, J.A. Pons, Pablo Ramírez, Pablo Pelegrı́n, Alberto Baroja‐Mazo	3
8	Characterization of P2X7 Receptors in Human Blood Cells 2022 ·Methods in molecular biology ·(unknown), Alberto Baroja‐Mazo, Pablo Pelegrı́n	2
9	Characterization of Novel Pathogenic Variants Leading to Caspase-8 Cleavage-Resistant RIPK1-Induced Autoinflammatory Syndrome 2022 ·Journal of Clinical Immunology ·(unknown), (unknown), (unknown), Diego Angosto-Bazarra, (unknown), Anna Mensa‐Vilaró, (unknown), Alberto Baroja‐Mazo, (unknown), (unknown), (unknown), Susana Plaza, Jordi Yagüe, Ferrán Casals, Baldomero Oliva, (unknown), Pablo Pelegrı́n, Juan I. Aróstegui	11
10	Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity 2022 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), (unknown), L. Martínez‐Alarcón, Diego Angosto-Bazarra, Alberto Baroja‐Mazo, Pablo Pelegrı́n	22
11	Proteomics in Liver Transplantation: A Systematic Review 2021 ·Frontiers in Immunology ·Víctor López‐López, Fernando Pérez-Sánz, Carlos de Torre‐Minguela, (unknown), R Robles, Francisco Sánchez‐Bueno, J.A. Pons, Pablo Ramı́rez, Alberto Baroja‐Mazo	7
12	Saturation of acyl chains converts cardiolipin from an antagonist to an activator of Toll-like receptor-4 2019 ·Cellular and Molecular Life Sciences ·Malvina Pizzuto, Caroline Lonez, Alberto Baroja‐Mazo, Helios Martínez‐Banaclocha, Panagiotis Tourlomousis, Monique Gangloff, Pablo Pelegrı́n, Jean‐Marie Ruysschaert, Nicholas J. Gay, Clare Bryant	44
13	Extracellular adenosine reversibly inhibits the activation of human regulatory T cells and negatively influences the achievement of the operational tolerance in liver transplantation 2018 ·American Journal of Transplantation ·Alberto Baroja‐Mazo, Beatriz Revilla‐Nuin, (unknown), L. Martínez‐Alarcón, J.I. Herrero, Ali El‐Tayeb, Christa E. Müller, Pedro Aparício, Pablo Pelegrı́n, J.A. Pons	22
14	Immunosuppressive potency of mechanistic target of rapamycin inhibitors in solid-organ transplantation 2016 ·World Journal of Transplantation ·Alberto Baroja‐Mazo, Beatriz Revilla‐Nuin, Pablo Ramı́rez, J.A. Pons	63
15	Associated Liver Partition and Portal Vein Ligation (ALPPS) vs Selective Portal Vein Ligation (PVL) for Staged Hepatectomy in a Rat Model. Similar Regenerative Response? 2015 ·PLoS ONE ·(unknown), Beatriz Revilla‐Nuin, Carlos Martínez, Ángel Bernabé‐García, Alberto Baroja‐Mazo, Pascual Parrilla Paricio	35
16	The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response breakdown → 2014 ·Nature Immunology ·Alberto Baroja‐Mazo, Fatima Martín‐Sánchez, Ana Isabel Gómez Córdoba, Carlos Martínez, J. Amores, Vincent Compan, María Barberà-Cremades, Jordi Yagüe, Estíbaliz Ruiz‐Ortiz, Jordi Antón, Segundo Buján, Isabelle Couillin, David Brough, Juan I. Aróstegui, Pablo Pelegrı́n	640
17	The participation of plasma membrane hemichannels to purinergic signaling 2012 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Alberto Baroja‐Mazo, María Barberà-Cremades, Pablo Pelegrı́n	148
18	Novel macrophage polarization model: from gene expression to identification of new anti-inflammatory molecules 2010 ·Cellular and Molecular Life Sciences ·Gloria López‐Castejón, Alberto Baroja‐Mazo, Pablo Pelegrı́n	72
19	An acetyl-CoA synthetase not encoded by the facA gene is expressed under carbon starvation in Phycomyces blakesleeanus 2005 ·Research in Microbiology ·(unknown), Javier Rúa, Eusebio Perdiguero, Pilar del Valle, (unknown), Alberto Baroja‐Mazo, Dolores de Arriaga	6
20	A Transplasma Membrane Redox System in Phycomyces blakesleeanus: Properties of a Ferricyanide Reductase Activity Regulated by Iron Level and Vitamin K3 2004 ·Journal of Bioenergetics and Biomembranes ·Alberto Baroja‐Mazo, Pilar del Valle, Javier Rúa, (unknown), (unknown), Dolores de Arriaga	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact